Register | Forgot password?
Switch to Arabic
Monday, December 7 - 2009

New line of testing introduced to identify HPV virus

  • United Arab Emirates: Wednesday, November 04 - 2009 at 15:59
  • PRESS RELEASE

Dubai's Histopathology & Specialty Laboratory (HSL) - part of Gulf Healthcare International's Medsol network of laboratories - has introduced a new line of testing for Human papillomavirus 'HPV'. HSL is the first regional private sector lab to introduce the new service in house.

Article continues below
 
HPVs are a group of more than 100 related viruses and some types of HPV - high-risk, oncogenic, or carcinogenic HPVs - are associated with certain types of cervical cancer in women. While most HPV infections occur without any symptoms, HPV infection sometimes persists for many years and can increase the risk of developing cervical cancer.

The new testing process is combined with HSL's Liquid Base Cytology service (for cervical screening) and enables the clinician to request HPV typing as well from the same specimen, promoting easier diagnosis.

Dr. Samar Hourieh, MD, director of Histopathology and Specialty Laboratory said:
"The new HPV test is an important step for identifying and treating cervical cancer, as well as raising awareness and improving women's health across the MENA region."


Established in 2000, HSL offers comprehensive and high quality Histopathology and Cytology services in the private sector.
Also consider reading:
Log in to request more information from Gulf Healthcare International (GHI)

Notes and media contacts

About Medsol and Gulf Healthcare International
Medsol is a part of Gulf Healthcare International (GHI). Medsol provides pathology testing services via a network of independent and hospital laboratories across the MENA region. Medsol presently has 15 operational labs across MENA - nine in UAE, five in Kuwait and one in KSA. As part of the aggressive growth plans, Medsol plans to have about 20 operational labs across the MENA in 2009.

GHI is owned by the private equity funds managed by Global Investment House's alternative investment funds group, Global Capital Management Kuwait. GHI is a healthcare management company based in Dubai Healthcare City and operating in the Middle East and North Africa (MENA) region. The company's charter is to use international best practices in management to provide high quality and specialized healthcare to the people of the region.

Medsol
Al Faris Building, office101
P.O.Box-2547,
Dubai Healthcare City,UAE.
Phone: 00971-04-3624830

About Global Capital Management
Global Capital Management's private equity team currently manages about USD 3 billion of private equity assets for clients. The team is one of the largest teams in the MENA region with about 45 well qualified professionals comprising of 12 nationalities, providing a local perspective for deals in all target markets.

The team has a cumulative work experience of over 300 years ranging from private equity, investment banking, advisory, venture capital, financial research, credit rating and audit across varied sectors. The team has invested nearly $1.5 billion in 55 transactions across 11 sectors in Middle East and North Africa, Turkey, South Asia & China during past 4 years.

The team has also successfully managed 16 exits generating an IRR of around 67% as of December 2008 for its existing investor base which comprises international and MENA institutional investors.

For more information please contact:
Samantha Armstrong at The PR Company
+971 501582958

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions